Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

AlamarBio-NewLaunch

More Like This

PR Newswire associated0

Alamar Biosciences Announces the Commercial Launch of Ultra-high Sensitivity NULISAseq™ CNS Disease Panel 120 and NULISAqpcr™ pTau-217 Assays

PR Newswire associated0

Alamar Biosciences Unveils NULISAseq Inflammation Panel AQ

PR Newswire associated0

Alamar Biosciences Announces Commercial Launch of the ARGO™ HT System and the NULISAseq™ Inflammation Panel 250 for Ultra-high Sensitivity Protein Analysis in Biofluids

Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research

PR Newswire associated0

Alamar Biosciences launches the NULISAqpcr™ Custom Assay Development Kit to advance the development of novel biomarker assays for clinical research

PR Newswire associated0

Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers

PR Newswire associated0

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

PR Newswire associated0

Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease